Status:
COMPLETED
Impact of Radiation Therapy on Breast Conservation in DCIS
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborating Sponsors:
Patient-Centered Outcomes Research Institute
Conditions:
DCIS
Eligibility:
FEMALE
21+ years
Brief Summary
Large regional variation exists in the use of radiotherapy after breast-conserving surgery (BCS) for ductal carcinoma in situ (DCIS). Although patients who do not receive initial radiotherapy for DCIS...
Detailed Description
Patients and their physicians are often confronted with a decision between more intensive versus less intensive treatment for a particular diagnosis. Quality decision-making between these options requ...
Eligibility Criteria
Inclusion
- This study used data from SEER and SEER-Medicare.
Exclusion
Key Trial Info
Start Date :
August 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2017
Estimated Enrollment :
3436 Patients enrolled
Trial Details
Trial ID
NCT02248662
Start Date
August 1 2013
End Date
January 1 2017
Last Update
September 6 2019
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02215
2
Harvard Pilgrim Health Care Institute
Boston, Massachusetts, United States, 02215
3
Dartmouth College
Hanover, New Hampshire, United States, 03755
4
University of Wisconsin
Madison, Wisconsin, United States, 53792